Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported fourth quarter 2013 loss of 27 cents per share, unchanged from the year-ago period, but narrower than the Zacks Consensus Estimate of a loss of 28 cents per share. Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares after opening at $18.62 moved to $18.97 on last trade day and at the end of the day closed at $16.95. Company price to sales ratio in past twelve months was calculated as 368.97 and price to cash ratio as 4.99. Celldex Therapeutics, Inc. (NASDAQ:CLDX) showed a negative weekly performance of -21.24%.
Prana Biotechnology Ltd. (NASDAQ:PRAN) plunged as much as 76 percent in trading before U.S. exchanges opened after the company’s experimental drug for Alzheimer’s disease failed to help patients in a clinical trial. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares fell -0.30% in last trading session and ended the day on $9.86. PRAN return on equity ratio is recorded as -143.60% and its return on assets is -113.60%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) yearly performance is 317.80%.
On April 10, 2014, Keith Murphy, Chief Executive Officer and President of Organovo Holdings, Inc. (NYSEMKT:ONVO), will be participating in a live webcast presentation to investors via RetailInvestorConferences.com. Organovo Holdings Inc. (NYSEMKT:ONVO) shares moved up 2.35% in last trading session and was closed at $7.41, while trading in range of $7.12 – $7.69. Organovo Holdings Inc. (NYSEMKT:ONVO) year to date (YTD) performance is -33.06%.
InterOil Corporation (NYSE:IOC) announced today record revenues and products sold in its financial results for the full year ending December 31, 2013. InterOil Corporation (USA) (NYSE:IOC) weekly performance is 5.63%. On last trading day company shares ended up $63.41. InterOil Corporation (USA) (NYSE:IOC) distance from 50-day simple moving average (SMA50) is 13.25%. Analysts mean target price for the company is $101.67.
Leave a Reply